BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 2169335)

  • 1. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
    Moll UM; Youngleib GL; Rosinski KB; Quigley JP
    Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells.
    Winwood PJ; Schuppan D; Iredale JP; Kawser CA; Docherty AJ; Arthur MJ
    Hepatology; 1995 Jul; 22(1):304-15. PubMed ID: 7601425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.
    Brown PD; Levy AT; Margulies IM; Liotta LA; Stetler-Stevenson WG
    Cancer Res; 1990 Oct; 50(19):6184-91. PubMed ID: 2169338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
    Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
    Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea.
    Fini ME; Girard MT
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1779-88. PubMed ID: 2170294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes.
    Davis GE; Martin BM
    Cancer Res; 1990 Feb; 50(4):1113-20. PubMed ID: 2297760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells.
    Shi YE; Torri J; Yieh L; Wellstein A; Lippman ME; Dickson RB
    Cancer Res; 1993 Mar; 53(6):1409-15. PubMed ID: 8383010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
    Stetler-Stevenson WG; Krutzsch HC; Liotta LA
    Matrix Suppl; 1992; 1():299-306. PubMed ID: 1480041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
    Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
    J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
    Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neutrophil gelatinase is a collagenase type IV.
    Morel F; Berthier S; Guillot M; Zaoui P; Massoubre C; Didier F; Vignais PV
    Biochem Biophys Res Commun; 1993 Feb; 191(1):269-74. PubMed ID: 8383490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
    Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
    Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
    Banda MJ; Howard EW; Herron GS; Apodaca G
    Matrix Suppl; 1992; 1():294-8. PubMed ID: 1480040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent collagenase and gelatinase from human neutrophils and their activation.
    Tschesche H; Knäuper V; Krämer S; Michaelis J; Oberhoff R; Reinke H
    Matrix Suppl; 1992; 1():245-55. PubMed ID: 1480034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.
    Murphy G; Ward R; Hembry RM; Reynolds JJ; Kühn K; Tryggvason K
    Biochem J; 1989 Mar; 258(2):463-72. PubMed ID: 2539808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts.
    Chen JM; Aimes RT; Ward GR; Youngleib GL; Quigley JP
    J Biol Chem; 1991 Mar; 266(8):5113-21. PubMed ID: 1848240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells.
    Azzam HS; Thompson EW
    Cancer Res; 1992 Aug; 52(16):4540-4. PubMed ID: 1322793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.
    Apodaca G; Rutka JT; Bouhana K; Berens ME; Giblin JR; Rosenblum ML; McKerrow JH; Banda MJ
    Cancer Res; 1990 Apr; 50(8):2322-9. PubMed ID: 2156617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells.
    Lauricella-Lefebvre MA; Castronovo V; Sato H; Seiki M; French DL; Merville MP
    Invasion Metastasis; 1993; 13(6):289-300. PubMed ID: 7860222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human 92-kDa type IV collagenase/gelatinase from baculovirus-infected insect cells: expression, purification, and characterization.
    George HJ; Marchand P; Murphy K; Wiswall BH; Dowling R; Giannaras J; Hollis GF; Trzaskos JM; Copeland RA
    Protein Expr Purif; 1997 Jun; 10(1):154-61. PubMed ID: 9179302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.